The consortium of the project "European Network for Cell Imaging and Tracking Expertise" (ENCITE) has the ambitious mission to develop and test new MR and optical imaging methods and biomarkers to draw a more comprehensive picture of cell fate and the reaction of the immune system.
Each year 350,000 new cases of breast cancer are detected in the European Union, but a lack of effective technology to assist in cases that are difficult to diagnose means some cases go undetected or are incorrectly diagnosed.